HDL-Atherosclerosis Treatment Study
id:
hdl-atherosclerosis-treatment-study-201-447014
title:
HDL-Atherosclerosis Treatment Study
text:
The HDL-Atherosclerosis Treatment Study, also known as HATS, was a three-year double-blind trial involving 160 people with coronary heart disease (CHD) who had a low HDL and near normal LDL. The study compared a combination of simvastatin and niacin with antioxidant vitamin therapy. Using angiography, coronary artery stenosis progressed when using placebo or antioxidant alone, and regressed with the combination of simvastatin and niacin. The study demonstrated a 90% reduction in CHD death, nonfa
brand slug:
wiki
category slug:
encyclopedia
description:
Pharmaceutical clinical trial
original url:
https://en.wikipedia.org/wiki/HDL-Atherosclerosis_Treatment_Study
date created:
date modified:
2023-11-26T07:09:08Z
main entity:
{"identifier":"Q64790705","url":"https://www.wikidata.org/entity/Q64790705"}
image:
fields total:
13
integrity:
14